Persistent Use Higher With New Generation Beta-Blockers

This article originally appeared here.
Share this content:
Persistent Use Higher With New Generation Beta-Blockers
Persistent Use Higher With New Generation Beta-Blockers

FRIDAY, July 22, 2016 (HealthDay News) -- Persistent use of antihypertensive treatments is greater with the new generation of beta-blockers, compared to atenolol, according to a study published in the August issue of Cardiovascular Therapeutics.

Yun Jung Choi, from Hanyang University in South Korea, and colleagues analyzed persistent use of antihypertensive medications among 9,978 patients (≥18 years) with newly diagnosed hypertension in 2012. The participants were without hypertension-related complication and had initiated treatment with beta-blocker monotherapy.

The researchers found that the rate of treatment persistence was higher in the non-atenolol group (P < 0.0001), and time to treatment discontinuation was earlier in the atenolol group (P < 0.0001). Compared to atenolol, new generation beta-blockers demonstrated a lower risk of treatment discontinuation (hazard ratio [HR], 0.91), with notable improvement seen with carvedilol and nebivolol (HRs, 0.74 and 0.79, respectively). Betaxolol showed a substantially greater hazard for discontinuation versus atenolol.

"This study demonstrated meaningful improvement in treatment persistence with new generation beta-blockers compared to atenolol, with betaxolol as exception," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Deaths, Cardiac Arrest Not Rare in Triathlon Participants

Deaths, Cardiac Arrest Not Rare in Triathlon Participants

Incidence of death or cardiac arrest 1.74 per 100,000 participants; higher incidence in men, with age

ACP Does Not Support Legalization of Assisted Suicide

ACP Does Not Support Legalization of Assisted Suicide

Legalization would affect trust in the patient-physician relationship, and in the medical profession

AAP: Epinephrine Admin Training Needed in Many Schools

AAP: Epinephrine Admin Training Needed in Many Schools

In 2015 to 2016, 2.7 percent reported that epinephrine was administered by unlicensed staff

is free, fast, and customized just for you!

Already a member?

Sign In Now »